[English] 日本語
Yorodumi
- EMDB-27840: Cryo-EM density of BIRC6/casp-7 (clusters) -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: EMDB / ID: EMD-27840
TitleCryo-EM density of BIRC6/casp-7 (clusters)
Map datamain map (consensus refine)
Sample
  • Complex: BIRC6/casp-7
    • Protein or peptide: Baculoviral IAP repeat-containing protein 6
    • Protein or peptide: caspase-7Caspase 7
KeywordsUbiquitin / E3 ligase / Apoptosis / Autophagy / IAP / LIGASE
Function / homology
Function and homology information


caspase-7 / lymphocyte apoptotic process / spongiotrophoblast layer development / positive regulation of plasma membrane repair / labyrinthine layer development / ALK mutants bind TKIs / cellular response to staurosporine / cysteine-type endopeptidase activity involved in execution phase of apoptosis / SMAC, XIAP-regulated apoptotic response / Flemming body ...caspase-7 / lymphocyte apoptotic process / spongiotrophoblast layer development / positive regulation of plasma membrane repair / labyrinthine layer development / ALK mutants bind TKIs / cellular response to staurosporine / cysteine-type endopeptidase activity involved in execution phase of apoptosis / SMAC, XIAP-regulated apoptotic response / Flemming body / Activation of caspases through apoptosome-mediated cleavage / cysteine-type endopeptidase activity involved in apoptotic process / SMAC (DIABLO) binds to IAPs / SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes / fibroblast apoptotic process / microtubule organizing center / execution phase of apoptosis / cysteine-type endopeptidase inhibitor activity / Apoptotic cleavage of cellular proteins / ubiquitin conjugating enzyme activity / protein maturation / Signaling by ALK fusions and activated point mutants / Caspase-mediated cleavage of cytoskeletal proteins / cysteine-type peptidase activity / response to UV / striated muscle cell differentiation / regulation of cytokinesis / negative regulation of extrinsic apoptotic signaling pathway / protein catabolic process / RING-type E3 ubiquitin transferase / trans-Golgi network / protein processing / spindle pole / ubiquitin-protein transferase activity / regulation of cell population proliferation / heart development / peptidase activity / midbody / neuron apoptotic process / cellular response to lipopolysaccharide / cell population proliferation / aspartic-type endopeptidase activity / protein ubiquitination / endosome / defense response to bacterium / cell cycle / cell division / cysteine-type endopeptidase activity / protein phosphorylation / centrosome / apoptotic process / positive regulation of cell population proliferation / negative regulation of apoptotic process / proteolysis / extracellular space / RNA binding / nucleoplasm / membrane / nucleus / cytosol / cytoplasm
Similarity search - Function
Baculoviral IAP repeat-containing protein 6 / Baculoviral IAP repeat-containing protein 6 / BIR repeat / Inhibitor of Apoptosis domain / BIR repeat profile. / Baculoviral inhibition of apoptosis protein repeat / Peptidase family C14A, His active site / Caspase family histidine active site. / Peptidase C14, caspase non-catalytic subunit p10 / Peptidase family C14A, cysteine active site ...Baculoviral IAP repeat-containing protein 6 / Baculoviral IAP repeat-containing protein 6 / BIR repeat / Inhibitor of Apoptosis domain / BIR repeat profile. / Baculoviral inhibition of apoptosis protein repeat / Peptidase family C14A, His active site / Caspase family histidine active site. / Peptidase C14, caspase non-catalytic subunit p10 / Peptidase family C14A, cysteine active site / Caspase family cysteine active site. / Caspase family p10 domain profile. / Peptidase C14A, caspase catalytic domain / Caspase, interleukin-1 beta converting enzyme (ICE) homologues / Peptidase C14, p20 domain / Caspase family p20 domain profile. / : / Caspase domain / Caspase-like domain superfamily / Ubiquitin-conjugating enzyme E2, catalytic domain homologues / Ubiquitin-conjugating enzyme E2 / Ubiquitin-conjugating enzyme / Ubiquitin-conjugating (UBC) core domain profile. / Ubiquitin-conjugating enzyme/RWD-like
Similarity search - Domain/homology
Caspase-7 / Baculoviral IAP repeat-containing protein 6
Similarity search - Component
Biological speciesHomo sapiens (human)
Methodsingle particle reconstruction / cryo EM / Resolution: 3.01 Å
AuthorsHunkeler M / Fischer ES
Funding support United States, 2 items
OrganizationGrant numberCountry
National Institutes of Health/National Cancer Institute (NIH/NCI)CA066996 United States
The Mark Foundation19-001-ELA United States
CitationJournal: Science / Year: 2023
Title: Structures of BIRC6-client complexes provide a mechanism of SMAC-mediated release of caspases.
Authors: Moritz Hunkeler / Cyrus Y Jin / Eric S Fischer /
Abstract: Tight regulation of apoptosis is essential for metazoan development and prevents diseases such as cancer and neurodegeneration. Caspase activation is central to apoptosis, and inhibitor of apoptosis ...Tight regulation of apoptosis is essential for metazoan development and prevents diseases such as cancer and neurodegeneration. Caspase activation is central to apoptosis, and inhibitor of apoptosis proteins (IAPs) are the principal actors that restrain caspase activity and are therefore attractive therapeutic targets. IAPs, in turn, are regulated by mitochondria-derived proapoptotic factors such as SMAC and HTRA2. Through a series of cryo-electron microscopy structures of full-length human baculoviral IAP repeat-containing protein 6 (BIRC6) bound to SMAC, caspases, and HTRA2, we provide a molecular understanding for BIRC6-mediated caspase inhibition and its release by SMAC. The architecture of BIRC6, together with near-irreversible binding of SMAC, elucidates how the IAP inhibitor SMAC can effectively control a processive ubiquitin ligase to respond to apoptotic stimuli.
History
DepositionAug 15, 2022-
Header (metadata) releaseFeb 22, 2023-
Map releaseFeb 22, 2023-
UpdateJan 17, 2024-
Current statusJan 17, 2024Processing site: RCSB / Status: Released

-
Structure visualization

Supplemental images

Downloads & links

-
Map

FileDownload / File: emd_27840.map.gz / Format: CCP4 / Size: 166.4 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES)
Annotationmain map (consensus refine)
Voxel sizeX=Y=Z: 1.2 Å
Density
Contour LevelBy AUTHOR: 0.359
Minimum - Maximum-1.3773768 - 2.4984968
Average (Standard dev.)0.0016790534 (±0.0540623)
SymmetrySpace group: 1
Details

EMDB XML:

Map geometry
Axis orderXYZ
Origin000
Dimensions352352352
Spacing352352352
CellA=B=C: 422.40002 Å
α=β=γ: 90.0 °

-
Supplemental data

+
Mask #1

Fileemd_27840_msk_1.map
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Mask #2

Fileemd_27840_msk_2.map
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: cluster 1

Fileemd_27840_additional_1.map
Annotationcluster 1
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: cluster 10

Fileemd_27840_additional_10.map
Annotationcluster 10
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: cluster 2

Fileemd_27840_additional_2.map
Annotationcluster 2
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: cluster 3

Fileemd_27840_additional_3.map
Annotationcluster 3
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: cluster 4

Fileemd_27840_additional_4.map
Annotationcluster 4
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: cluster 5

Fileemd_27840_additional_5.map
Annotationcluster 5
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: cluster 6

Fileemd_27840_additional_6.map
Annotationcluster 6
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: cluster 7

Fileemd_27840_additional_7.map
Annotationcluster 7
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: cluster 8

Fileemd_27840_additional_8.map
Annotationcluster 8
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Additional map: cluster 9

Fileemd_27840_additional_9.map
Annotationcluster 9
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Half map: half map 1

Fileemd_27840_half_map_1.map
Annotationhalf map 1
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

+
Half map: half map 2

Fileemd_27840_half_map_2.map
Annotationhalf map 2
Projections & Slices
AxesZYX

Projections

Slices (1/2)
Density Histograms

-
Sample components

-
Entire : BIRC6/casp-7

EntireName: BIRC6/casp-7
Components
  • Complex: BIRC6/casp-7
    • Protein or peptide: Baculoviral IAP repeat-containing protein 6
    • Protein or peptide: caspase-7Caspase 7

-
Supramolecule #1: BIRC6/casp-7

SupramoleculeName: BIRC6/casp-7 / type: complex / ID: 1 / Parent: 0 / Macromolecule list: all
Source (natural)Organism: Homo sapiens (human)
Molecular weightTheoretical: 1.132 MDa

-
Macromolecule #1: Baculoviral IAP repeat-containing protein 6

MacromoleculeName: Baculoviral IAP repeat-containing protein 6 / type: protein_or_peptide / ID: 1 / Enantiomer: LEVO / EC number: Ligases
Source (natural)Organism: Homo sapiens (human)
Recombinant expressionOrganism: Homo sapiens (human)
SequenceString: MGDWSHPQFE KSGGGSGGLE VLFQGPSRTM VTGGGAAPPG TVTEPLPSVI VLSAGRKMAA AAAAASGPGC SSAAGAGAAG VSEWLVLRDG CMHCDADGLH SLSYHPALNA ILAVTSRGTI KVIDGTSGAT LQASALSAKP GGQVKCQYIS AVDKVIFVDD YAVGCRKDLN ...String:
MGDWSHPQFE KSGGGSGGLE VLFQGPSRTM VTGGGAAPPG TVTEPLPSVI VLSAGRKMAA AAAAASGPGC SSAAGAGAAG VSEWLVLRDG CMHCDADGLH SLSYHPALNA ILAVTSRGTI KVIDGTSGAT LQASALSAKP GGQVKCQYIS AVDKVIFVDD YAVGCRKDLN GILLLDTALQ TPVSKQDDVV QLELPVTEAQ QLLSACLEKV DISSTEGYDL FITQLKDGLK NTSHETAANH KVAKWATVTF HLPHHVLKSI ASAIVNELKK INQNVAALPV ASSVMDRLSY LLPSARPELG VGPGRSVDRS LMYSEANRRE TFTSWPHVGY RWAQPDPMAQ AGFYHQPASS GDDRAMCFTC SVCLVCWEPT DEPWSEHERH SPNCPFVKGE HTQNVPLSVT LATSPAQFPC TDGTDRISCF GSGSCPHFLA AATKRGKICI WDVSKLMKVH LKFEINAYDP AIVQQLILSG DPSSGVDSRR PTLAWLEDSS SCSDIPKLEG DSDDLLEDSD SEEHSRSDSV TGHTSQKEAM EVSLDITALS ILQQPEKLQW EIVANVLEDT VKDLEELGAN PCLTNSKSEK TKEKHQEQHN IPFPCLLAGG LLTYKSPATS PISSNSHRSL DGLSRTQGES ISEQGSTDNE SCTNSELNSP LVRRTLPVLL LYSIKESDEK AGKIFSQMNN IMSKSLHDDG FTVPQIIEME LDSQEQLLLQ DPPVTYIQQF ADAAANLTSP DSEKWNSVFP KPGTLVQCLR LPKFAEEENL CIDSITPCAD GIHLLVGLRT CPVESLSAIN QVEALNNLNK LNSALCNRRK GELESNLAVV NGANISVIQH ESPADVQTPL IIQPEQRNVS GGYLVLYKMN YATRIVTLEE EPIKIQHIKD PQDTITSLIL LPPDILDNRE DDCEEPIEDM QLTSKNGFER EKTSDISTLG HLVITTQGGY VKILDLSNFE ILAKVEPPKK EGTEEQDTFV SVIYCSGTDR LCACTKGGEL HFLQIGGTCD DIDEADILVD GSLSKGIEPS SEGSKPLSNP SSPGISGVDL LVDQPFTLEI LTSLVELTRF ETLTPRFSAT VPPCWVEVQQ EQQQRRHPQH LHQQHHGDAA QHTRTWKLQT DSNSWDEHVF ELVLPKACMV GHVDFKFVLN SNITNIPQIQ VTLLKNKAPG LGKVNALNIE VEQNGKPSLV DLNEEMQHMD VEESQCLRLC PFLEDHKEDI LCGPVWLASG LDLSGHAGML TLTSPKLVKG MAGGKYRSFL IHVKAVNERG TEEICNGGMR PVVRLPSLKH QSNKGYSLAS LLAKVAAGKE KSSNVKNENT SGTRKSENLR GCDLLQEVSV TIRRFKKTSI SKERVQRCAM LQFSEFHEKL VNTLCRKTDD GQITEHAQSL VLDTLCWLAG VHSNGPGSSK EGNENLLSKT RKFLSDIVRV CFFEAGRSIA HKCARFLALC ISNGKCDPCQ PAFGPVLLKA LLDNMSFLPA ATTGGSVYWY FVLLNYVKDE DLAGCSTACA SLLTAVSRQL QDRLTPMEAL LQTRYGLYSS PFDPVLFDLE MSGSSCKNVY NSSIGVQSDE IDLSDVLSGN GKVSSCTAAE GSFTSLTGLL EVEPLHFTCV STSDGTRIER DDAMSSFGVT PAVGGLSSGT VGEASTALSS AAQVALQSLS HAMASAEQQL QVLQEKQQQL LKLQQQKAKL EAKLHQTTAA AAAAASAVGP VHNSVPSNPV AAPGFFIHPS DVIPPTPKTT PLFMTPPLTP PNEAVSVVIN AELAQLFPGS VIDPPAVNLA AHNKNSNKSR MNPLGSGLAL AISHASHFLQ PPPHQSIIIE RMHSGARRFV TLDFGRPILL TDVLIPTCGD LASLSIDIWT LGEEVDGRRL VVATDISTHS LILHDLIPPP VCRFMKITVI GRYGSTNARA KIPLGFYYGH TYILPWESEL KLMHDPLKGE GESANQPEID QHLAMMVALQ EDIQCRYNLA CHRLETLLQS IDLPPLNSAN NAQYFLRKPD KAVEEDSRVF SAYQDCIQLQ LQLNLAHNAV QRLKVALGAS RKMLSETSNP EDLIQTSSTE QLRTIIRYLL DTLLSLLHAS NGHSVPAVLQ STFHAQACEE LFKHLCISGT PKIRLHTGLL LVQLCGGERW WGQFLSNVLQ ELYNSEQLLI FPQDRVFMLL SCIGQRSLSN SGVLESLLNL LDNLLSPLQP QLPMHRRTEG VLDIPMISWV VMLVSRLLDY VATVEDEAAA AKKPLNGNQW SFINNNLHTQ SLNRSSKGSS SLDRLYSRKI RKQLVHHKQQ LNLLKAKQKA LVEQMEKEKI QSNKGSSYKL LVEQAKLKQA TSKHFKDLIR LRRTAEWSRS NLDTEVTTAK ESPEIEPLPF TLAHERCISV VQKLVLFLLS MDFTCHADLL LFVCKVLARI ANATRPTIHL CEIVNEPQLE RLLLLLVGTD FNRGDISWGG AWAQYSLTCM LQDILAGELL APVAAEAMEE GTVGDDVGAT AGDSDDSLQQ SSVQLLETID EPLTHDITGA PPLSSLEKDK EIDLELLQDL MEVDIDPLDI DLEKDPLAAK VFKPISSTWY DYWGADYGTY NYNPYIGGLG IPVAKPPANT EKNGSQTVSV SVSQALDARL EVGLEQQAEL MLKMMSTLEA DSILQALTNT SPTLSQSPTG TDDSLLGGLQ AANQTSQLII QLSSVPMLNV CFNKLFSMLQ VHHVQLESLL QLWLTLSLNS SSTGNKENGA DIFLYNANRI PVISLNQASI TSFLTVLAWY PNTLLRTWCL VLHSLTLMTN MQLNSGSSSA IGTQESTAHL LVSDPNLIHV LVKFLSGTSP HGTNQHSPQV GPTATQAMQE FLTRLQVHLS STCPQIFSEF LLKLIHILST ERGAFQTGQG PLDAQVKLLE FTLEQNFEVV SVSTISAVIE SVTFLVHHYI TCSDKVMSRS GSDSSVGARA CFGGLFANLI RPGDAKAVCG EMTRDQLMFD LLKLVNILVQ LPLSGNREYS ARVSVTTNTT DSVSDEEKVS GGKDGNGSST SVQGSPAYVA DLVLANQQIM SQILSALGLC NSSAMAMIIG ASGLHLTKHE NFHGGLDAIS VGDGLFTILT TLSKKASTVH MMLQPILTYM ACGYMGRQGS LATCQLSEPL LWFILRVLDT SDALKAFHDM GGVQLICNNM VTSTRAIVNT ARSMVSTIMK FLDSGPNKAV DSTLKTRILA SEPDNAEGIH NFAPLGTITS SSPTAQPAEV LLQATPPHRR ARSAAWSYIF LPEEAWCDLT IHLPAAVLLK EIHIQPHLAS LATCPSSVSV EVSADGVNML PLSTPVVTSG LTYIKIQLVK AEVASAVCLR LHRPRDASTL GLSQIKLLGL TAFGTTSSAT VNNPFLPSED QVSKTSIGWL RLLHHCLTHI SDLEGMMASA AAPTANLLQT CAALLMSPYC GMHSPNIEVV LVKIGLQSTR IGLKLIDILL RNCAASGSDP TDLNSPLLFG RLNGLSSDST IDILYQLGTT QDPGTKDRIQ ALLKWVSDSA RVAAMKRSGR MNYMCPNSST VEYGLLMPSP SHLHCVAAIL WHSYELLVEY DLPALLDQEL FELLFNWSMS LPCNMVLKKA VDSLLCSMCH VHPNYFSLLM GWMGITPPPV QCHHRLSMTD DSKKQDLSSS LTDDSKNAQA PLALTESHLA TLASSSQSPE AIKQLLDSGL PSLLVRSLAS FCFSHISSSE SIAQSIDISQ DKLRRHHVPQ QCNKMPITAD LVAPILRFLT EVGNSHIMKD WLGGSEVNPL WTALLFLLCH SGSTSGSHNL GAQQTSARSA SLSSAATTGL TTQQRTAIEN ATVAFFLQCI SCHPNNQKLM AQVLCELFQT SPQRGNLPTS GNISGFIRRL FLQLMLEDEK VTMFLQSPCP LYKGRINATS HVIQHPMYGA GHKFRTLHLP VSTTLSDVLD RVSDTPSITA KLISEQKDDK EKKNHEEKEK VKAENGFQDN YSVVVASGLK SQSKRAVSAT PPRPPSRRGR TIPDKIGSTS GAEAANKIIT VPVFHLFHKL LAGQPLPAEM TLAQLLTLLY DRKLPQGYRS IDLTVKLGSR VITDPSLSKT DSYKRLHPEK DHGDLLASCP EDEALTPGDE CMDGILDESL LETCPIQSPL QVFAGMGGLA LIAERLPMLY PEVIQQVSAP VVTSTTQEKP KDSDQFEWVT IEQSGELVYE APETVAAEPP PIKSAVQTMS PIPAHSLAAF GLFLRLPGYA EVLLKERKHA QCLLRLVLGV TDDGEGSHIL QSPSANVLPT LPFHVLRSLF STTPLTTDDG VLLRRMALEI GALHLILVCL SALSHHSPRV PNSSVNQTEP QVSSSHNPTS TEEQQLYWAK GTGFGTGSTA SGWDVEQALT KQRLEEEHVT CLLQVLASYI NPVSSAVNGE AQSSHETRGQ NSNALPSVLL ELLSQSCLIP AMSSYLRNDS VLDMARHVPL YRALLELLRA IASCAAMVPL LLPLSTENGE EEEEQSECQT SVGTLLAKMK TCVDTYTNRL RSKRENVKTG VKPDASDQEP EGLTLLVPDI QKTAEIVYAA TTSLRQANQE KKLGEYSKKA AMKPKPLSVL KSLEEKYVAV MKKLQFDTFE MVSEDEDGKL GFKVNYHYMS QVKNANDANS AARARRLAQE AVTLSTSLPL SSSSSVFVRC DEERLDIMKV LITGPADTPY ANGCFEFDVY FPQDYPSSPP LVNLETTGGH SVRFNPNLYN DGKVCLSILN TWHGRPEEKW NPQTSSFLQV LVSVQSLILV AEPYFNEPGY ERSRGTPSGT QSSREYDGNI RQATVKWAML EQIRNPSPCF KEVIHKHFYL KRVEIMAQCE EWIADIQQYS SDKRVGRTMS HHAAALKRHT AQLREELLKL PCPEGLDPDT DDAPEVCRAT TGAEETLMHD QVKPSSSKEL PSDFQL

UniProtKB: Baculoviral IAP repeat-containing protein 6

-
Macromolecule #2: caspase-7

MacromoleculeName: caspase-7 / type: protein_or_peptide / ID: 2 / Enantiomer: LEVO / EC number: caspase-7
Source (natural)Organism: Homo sapiens (human)
Recombinant expressionOrganism: Escherichia coli (E. coli)
SequenceString: MADDQGCIEE QGVEDSANED SVDAKPDRSS FVPSLFSKKK KNVTMRSIKT TRDRVPTYQY NMNFEKLGKC IIINNKNFDK VTGMGVRNGT DKDAEALFKC FRSLGFDVIV YNDCSCAKMQ DLLKKASEED HTNAACFACI LLSHGEENVI YGKDGVTPIK DLTAHFRGDR ...String:
MADDQGCIEE QGVEDSANED SVDAKPDRSS FVPSLFSKKK KNVTMRSIKT TRDRVPTYQY NMNFEKLGKC IIINNKNFDK VTGMGVRNGT DKDAEALFKC FRSLGFDVIV YNDCSCAKMQ DLLKKASEED HTNAACFACI LLSHGEENVI YGKDGVTPIK DLTAHFRGDR CKTLLEKPKL FFIQACRGTE LDDGIQADSG PINDTDANPR YKIPVEADFL FAYSTVPGYY SWRSPGRGSW FVQALCSILE EHGKDLEIMQ ILTRVNDRVA RHFESQSDDP HFHEKKQIPC VVSMLTKELY FSQLEHHHHH H

UniProtKB: Caspase-7

-
Experimental details

-
Structure determination

Methodcryo EM
Processingsingle particle reconstruction
Aggregation stateparticle

-
Sample preparation

Concentration3.1 mg/mL
BufferpH: 7.4
Component:
ConcentrationFormulaName
30.0 mMC8H18N2O4SHEPES
150.0 mMNaClSodium chlorideSodium chloride
3.0 mMC9H15O6PTCEP
GridModel: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 300 / Support film - Material: CARBON / Support film - topology: HOLEY / Support film - Film thickness: 12 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 60 sec. / Pretreatment - Atmosphere: AIR / Pretreatment - Pressure: 0.039 kPa
VitrificationCryogen name: ETHANE / Chamber humidity: 90 % / Chamber temperature: 283.15 K / Instrument: LEICA EM GP
Detailsadded CHAPSO to 0.4 mM

-
Electron microscopy

MicroscopeFEI TITAN KRIOS
Electron beamAcceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN
Electron opticsC2 aperture diameter: 50.0 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELDBright-field microscopy / Cs: 2.7 mm / Nominal defocus max: 1.9000000000000001 µm / Nominal defocus min: 0.8 µm / Nominal magnification: 105000
Specialist opticsEnergy filter - Name: GIF Bioquantum / Energy filter - Slit width: 20 eV
Sample stageSpecimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN
DetailsData collection in counting mode, using multi-shot scheme (9 holes per stage position, 2 movies per hole)
Image recordingFilm or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Detector mode: COUNTING / Digitization - Dimensions - Width: 5760 pixel / Digitization - Dimensions - Height: 4092 pixel / Digitization - Frames/image: 1-51 / Number grids imaged: 1 / Number real images: 18216 / Average exposure time: 2.5 sec. / Average electron dose: 54.387 e/Å2
Experimental equipment
Model: Titan Krios / Image courtesy: FEI Company

-
Image processing

Particle selectionNumber selected: 2420278
Startup modelType of model: OTHER / Details: ab initio
Initial angle assignmentType: MAXIMUM LIKELIHOOD / Software - Name: cryoSPARC
Final 3D classificationNumber classes: 8 / Software - Name: cryoSPARC
Final angle assignmentType: MAXIMUM LIKELIHOOD / Software - Name: cryoSPARC
Final reconstructionApplied symmetry - Point group: C1 (asymmetric) / Resolution.type: BY AUTHOR / Resolution: 3.01 Å / Resolution method: FSC 0.143 CUT-OFF / Software - Name: cryoSPARC / Number images used: 880343
FSC plot (resolution estimation)

-
Atomic model buiding 1

RefinementSpace: REAL / Protocol: OTHER

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more